Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary’s two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals. Par is a portfolio company of TPG, a leading global private investment firm with $55.7 billion of assets under management and with extensive experience in the healthcare sector.

The following is the list of scholars from PAR Sterile Products who currently serve as editors for one or more SciTechnol journals.

• Vinayagam Kannan, PhD

The following is the list of articles by scholars from PAR Sterile Products that are published in SciTechnol journals.

• Young Researchers Forum for Nano Pharmaceuticals 2020

  Short Communication: J Pharm Drug Deliv Res
  DOI:
  Drug Metabolism,Drug Properties,Drug safety databases,Drug Targeting
  
  • Full-text
  • PDF

• Tetracycline Sclerotherapy for Seroma: A Systematic Review

  Review Article: J Pharm Drug Deliv Res
  DOI:
  AlQ hatani A
  
  • Full-text
  • PDF

• Prodrug in Pharmaceutics

  Editorial: J Pharm Drug Deliv Res
  DOI:
  Bivash M
  
  • Full-text
  • PDF

• Bioavailability and Pharmaceuticals

  Editorial: J Pharm Drug Deliv Res
  DOI:
  Bivash M
  
  • Full-text
  • PDF

• 2020 Market Analysis of Pharmaceutical Formulations & Drug Delivery Conference October 30-31, 2020 | Vancouver, Canada

  Short Communication: J Pharm Drug Deliv Res
  DOI:
  Bodhisattwa Chaudhuri
  
  • Full-text
  • PDF

• Development of Simple, Facile Spectrophotometric Method for Determination of Metformin Hydrochloride in Aqueous Medium

  Research Article: J Pharm Drug Deliv Res, 9:1
  DOI:
  Sonali Garg, Pratima Sharma, Dhiraj Sud . 
  
  • Abstract
  • PDF

• Journal of Pharmaceutics and Drug Delivery Research

  Editorial: J Pharm Drug Deliv Res
  DOI:
  Neil Foster
  
  • Abstract
  • PDF